ucsf logobch logo

Sasha Gupta, MD

Neurology (Neuroimmunology) • Neurology
Multiple Sclerosis & Neuroinflammation Center Mission Bay
415-353-2069
ucsf logobch logo

Sasha Gupta, MD

Neurology (Neuroimmunology) • Neurology
Multiple Sclerosis & Neuroinflammation Center Mission Bay
415-353-2069

On this page

Education & training

Board certification

  • Neurology, American Board of Psychiatry and Neurology

Fellowship

  • Neuroimmunology, UCSF Benioff Children's Hosp San Francisco

Residency

  • Neurology, UCSF School of Medicine -GME

Internship

  • Neurology, UCSF School of Medicine -GME

Degree

  • MD, Yale University School of Medicine

Academic title

  • Adjunct Professor

Locations

    Reviews

    Average rating

    4.9
    4.9 out of 5 Stars
    64 ratings
    About provider reviews

    Showing 1-6 of 31 reviews

    Sort by
    • 5 out of 5 Stars
      August 25, 2026

      Dr.Gupta is the nicest and the first doctor to ever listen to what my problem was. And not judge me for my multiple sclerosis..

    • 5 out of 5 Stars
      August 20, 2026

      Dr. Gupta is very thorough and so kind. She made me feel cared for and understood

    • 5 out of 5 Stars
      July 22, 2026

      I'm grateful to have Sasha Gupta as my MS doctor.

    • 5 out of 5 Stars
      July 1, 2026

      Dr. Gupta saved my life. She is a keeper!

    • 5 out of 5 Stars
      May 12, 2026

      Exceptional care. Dr Gupta is kind, knowledgeable and thorough. Outstanding communicator.

    • 5 out of 5 Stars
      May 7, 2026

      Dr. Gupta is one of the BEST doctors I have seen in my 59 years. I have had MS since 2016

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.